Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07109869 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
A Phase 3 study of Vulvovaginal Candidiasis (VVC) and Vulvovaginal Candidiases, sponsored by pH-D Feminine Health.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
- 20
- Study locations
NCT07109869 is a Phase 3 study of Vulvovaginal Candidiasis (VVC) and Vulvovaginal Candidiases that is actively recruiting participants, run by pH-D Feminine Health. The registered enrollment target is 400 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT07109869, a Phase 3 study of Vulvovaginal Candidiasis (VVC) and Vulvovaginal Candidiases, is actively recruiting participants, sponsored by pH-D Feminine Health.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Boric acid
Study Locations (20)
Florida
- Project 4 Research Inc - Miami
- Entrust Clinical Research - Miami
- Felicidad Medical Research, LLC - Miami
- Better Life Clinical Research, LLC - Tampa
- Helping Hands Health Center - Tampa
North Carolina
- Cross Creek Medical Clinic, PA - Fayetteville
- Unified Women's Clinical Research - Raleigh - Raleigh
- Unified Women's Clinical Research - Lyndhurst Clinical Research - Winston-Salem
California
- Century Research Institute, Inc - Huntington Park
- Matrix Clinical Research - Los Angeles
Louisiana
- Clinical Trials Management, LLC - Northshore - Covington
- Praetorian Pharmaceutical Research - Marrero
Texas
- TMC Life Research, Inc - Houston
- SMS Clinical Research, LLC - Mesquite
Alabama
- Alliance for Multispecialty Research - Mobile - Mobile
Arizona
- Abby's Research Institute - Phoenix
Idaho
- Leavitt Clinical Research - Idaho Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-08-08 |
| Est. Completion | 2026-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07109869
The ClinicalTrials.gov registry entry for NCT07109869 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is pH-D Feminine Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vulvovaginal Candidiasis (VVC) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07109869 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, North Carolina, California.
Frequently Asked Questions
What is clinical trial NCT07109869 about?
NCT07109869 is a clinical study titled "Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis". This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
What is the current status of trial NCT07109869?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2025-08-08. Estimated completion is 2026-06.
What conditions does trial NCT07109869 study?
This clinical trial studies the following conditions: Vulvovaginal Candidiasis (VVC), Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital.
What interventions are being tested in trial NCT07109869?
The interventions under investigation include: Placebo (OTHER), Boric acid (DRUG).
Who is sponsoring clinical trial NCT07109869?
This trial is sponsored by pH-D Feminine Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07109869 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vulvovaginal Candidiasis (VVC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.